344 related articles for article (PubMed ID: 32859279)
1. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
2. Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
Appay R; Bielle F; Sievers P; Barets D; Fina F; Boutonnat J; Adam C; Gauchotte G; Godfraind C; Lhermitte B; Maurage CA; Meyronet D; Mokhtari K; Rousseau A; Tauziède-Espariat A; Tortel MC; Uro-Coste E; Burel-Vandenbos F; Chotard G; Pesce F; Varlet P; Colin C; Figarella-Branger D
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12813. PubMed ID: 35293634
[TBL] [Abstract][Full Text] [Related]
3. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
4. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.
Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490
[TBL] [Abstract][Full Text] [Related]
5. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication.
Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K
Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479
[TBL] [Abstract][Full Text] [Related]
6. Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.
Matsumura N; Nobusawa S; Ito J; Kakita A; Suzuki H; Fujii Y; Fukuda M; Iwasaki M; Nakasato N; Tominaga T; Natsume A; Mikami Y; Shinojima N; Yamazaki T; Nakazato Y; Hirato J; Yokoo H
J Neurooncol; 2019 May; 143(1):27-33. PubMed ID: 30825062
[TBL] [Abstract][Full Text] [Related]
7. A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.
Matyja E; Grajkowska W; Kunert P; Marchel A
Neuropathology; 2014 Oct; 34(5):491-8. PubMed ID: 24735014
[TBL] [Abstract][Full Text] [Related]
8. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
[TBL] [Abstract][Full Text] [Related]
9. FGFR- gene family alterations in low-grade neuroepithelial tumors.
Bale TA
Acta Neuropathol Commun; 2020 Feb; 8(1):21. PubMed ID: 32085805
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
11. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA mutation in a mixed dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal tumor, a case report and literature review.
Eye PG; Davidson L; Malafronte PJ; Cantrell S; Theeler BJ
J Neurol Sci; 2017 Feb; 373():280-284. PubMed ID: 28131206
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of a dysembryoplastic neuroepithelial tumor verified by a shared copy number gain of the tyrosine kinase domain of FGFR1.
Matsumura N; Natsume A; Maeda S; Aoki K; Yamazaki T; Nobusawa S; Yokoo H
Brain Tumor Pathol; 2020 Apr; 37(2):69-75. PubMed ID: 32297014
[TBL] [Abstract][Full Text] [Related]
14. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
[TBL] [Abstract][Full Text] [Related]
15. Mixed glioneuronal tumor: a dysembryoplastic neuroepithelial tumor with rosette-forming glioneuronal tumor component.
Xiong J; Ding L; Chen H; Chen H; Wang Y
Neuropathology; 2013 Aug; 33(4):431-5. PubMed ID: 23163721
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways.
Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914
[TBL] [Abstract][Full Text] [Related]
17. Immune Microenvironment and Lineage Tracing Help to Decipher Rosette-Forming Glioneuronal Tumors: A Multi-Omics Analysis.
Lerond J; Morisse MC; Letourneur Q; Gimonnet C; Navarro S; Gaspar C; Idbaih A; Bielle F
J Neuropathol Exp Neurol; 2022 Oct; 81(11):873-884. PubMed ID: 35984315
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of rosette-forming glioneuronal tumors.
Liu J; Lin F; Sun Y; Liu X
Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
[TBL] [Abstract][Full Text] [Related]
19. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H
Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
